Detection and Significance of Cell-Free DNA Mutation in Pleural Effusion in Patients with Advanced NSCLC

Man Qiao, Dongsheng Li, Yuan He, Cen Zhang, Hang Chi, Xiaoqiu Li, Qingming Cui, Shaoying Li, Ying Jiao, Yuan WeiEmergency 2022 · DOI · OpenAlex

Abstract

For the detection of EGFR gene mutation, the results of the pleural effusion specimens and the tumor pathological tissue specimens were well consistent and the detection of pleural effusion could be used as an alternative method when tissue specimens cannot be obtained. EGFR gene mutations are present in majority in patients with advanced NSCLC. The incidence of EGFR mutation is higher in nonsmokers, patients with lung adenocarcinoma, those with lymph node metastasis, those with high-expression CEA, and those with low-expression Cy21-1. The prognosis is better in patients with EGFR mutation.
BibTeX
@inproceedings{qiao2022detection,
  author = {Man Qiao and Dongsheng Li and Yuan He and Cen Zhang and Hang Chi and Xiaoqiu Li and Qingming Cui and Shaoying Li and Ying Jiao and Yuan Wei},
  title = {{Detection and Significance of Cell-Free DNA Mutation in Pleural Effusion in Patients with Advanced NSCLC}},
  booktitle = {Emergency},
  year = {2022},
  doi = {10.1155/2022/3112281},
}

Loading related content...

Figure